Toxicokinetics and toxicodynamics of paraquat accumulation in mouse brain

Experimental Neurology

Volumn 215, Issue 2, 2009, Pages 358-367

  Prasad, Kavita ^a,b   Tarasewicz, Elizabeth ^a,b   Mathew, Jason ^a,b   Strickland, Pamela A Ohman ^a   Buckley, Brian ^b,c   Richardson, Jason R ^a,b   Richfield, Eric K ^a,b  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

Dopamine system; Oxidative stress; Paraquat; Parkinson's disease; Toxicodynamics; Toxicokinetics

Indexed keywords

PARAQUAT; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINERGIC SYSTEM; LOCOMOTION; MALE; MORBIDITY; MORTALITY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; TOXICODYNAMICS; TOXICOKINETICS; TOXICOLOGY;

ANALYSIS OF VARIANCE; ANIMALS; BODY WEIGHT; BRAIN; BRAIN CHEMISTRY; CATECHOLAMINES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG ADMINISTRATION ROUTES; HERBICIDES; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; PARAQUAT; RANDOM ALLOCATION; TYROSINE 3-MONOOXYGENASE;

EID: 58149520138     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2008.11.003     Document Type: Article

References (40)

1. Barlow B.K., Bennice L., Thiruchelvam M.J., Cory-Slechta D.A., Ballatori N., and Richfield E.K. Selective dithiocarbamates increase synaptosomal dopamine content, brain concentration of paraquat and correlate with potentiation of MPTP and paraquat toxicity. J. Neurochem. 85 (2003) 1075-1086
2. Barlow B.K., Kochar J., Prasad K., Buckley B., Mirochnitchenko O., Richfield E.K., and Thiruchelvam M. Paraquat exposure during periods of neurodevelopment and the Parkinson's disease phenotype. Soc. Neurosci. Abstract. (2007) Poster # 254.17/M10, San Diego, CA. Session # 254, Parkinson's Disease Models and Mechanisms II
3. Battaglia G., Busceti C.L., Pontarelli F., Biagioni F., Fornai F., Paparelli A., Brunio V., Ruggieri S., and Nicolett F. Protective role of group-II metabotropic glutamate receptors against nigro-striatal degeneration induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Neuropharmacology 45 (2003) 155-166
4. Bowyer F.J., Tank A.W., Newport G.D., Slokker Jr. W., Ali S.F., and Holson R.R. The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum. J. Pharmacol. Exp. Ther. 260 2 (1992) 817-824
5. Bullivant C.M. Accidental poisoning by paraquat: report of two cases in man. Br. Med. J. 1 (1966) 1272-1273
6. California DPR (Dept of Pesticide Regulation), 2005. Summary of Pesticide Use Report Data 2005 Indexed by Commodity, 1-495.
7. Castello P.R., Drechesl D.A., and Patel M. Mitochondria are a major source of paraquat-induced reactive oxygen species production in the brain. J. Biol. Chem. 282 19 (2007) 14186-14193
8. Cocheme H.M., and Murphy M.P. Complex I is the major site of mitochondrial superoxide production by paraquat. J. Biol. Chem. 283 4 (2008) 1786-1798
9. Crutchfield K.C., and Dluzin D.E. Rotenone produces opposite effects upon mouse striatal dopamine function as a result of environmental temperature. Neurotox. Res. 91 (2006) 15-21
10. Dinis-Oliveira R.J., Remiao F., Carmo H., Duarte J.A., Sanchez Nararro A., Bastos M.L., and Carvalho F. Paraquat exposure as an etiological factor of Parkinson's disease. Neurotoxicology 26 (2006) 1110-1122
11. Georgievska B., Kirik D., and Björklund A. Aberrant sprouting and down-regulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer. Exp. Neurol. 177 (2002) 461-474
12. Haycock J.W., Becker L., Ang L., Furukawa Y., Hornykeiwicz O., and Kish S.J. Marked disparity between age-related changes in dopamine and other presynaptic dopaminergic markers in human striatum. J. Neurochem. 87 (2003) 574-585
13. He J., Xu H., Yang Y., Zhang X., and Li X.-M. Neuroprotective effects of olanzapine on methamphetamine-induced neurotoxicity are associated with an inhibition of hyperthermia and prevention of Bcl-2 decrease in rats. Brain Res. 1018 2 (2004) 186-192
14. Hertzman C., Wiens M., Bowering D., Snow B., and Calne D. Parkinson's disease: a case-control study of occupational and environmental risk factors. Am. J. Ind. Med. 17 (1990) 349-355
15. Keeling P.L., Pratt I.S., Aldridge W.N., and Smith L.L. The enhancement of paraquat toxicity in rats by 85% oxygen: lethality and cell-specific lung damage. Br. J. Exp. Pathol. 62 6 (1981) 643-654
16. Kissileff H.R. Food-associated drinking in the rat. J. Comp. Physiol. Psychol. 67 (1969) 284-300
17. Kogan F.J., Nichols W.K., and Gibb J.W. Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels. Eur. J. Pharmacol. 36 2 (1976) 363-371
18. Lapointe N., St-Hilaire M., Martinoli M.-G., Blanchet J., Gould P., Rouillard C., and Cicchetti F. Rotenone induces non-specific central nervous system and systemic toxicity. FASEB J. 18 (2004) 717-719
19. Liou H.H., Tsai M.C., Chen C.J., Jeng J.S., Chang Y.C., Chen S.Y., and Chen R.C. Environmental risk factors and Parkinson's disease: a case-control study in Taiwan. Neurology 48 (1997) 1583-1588
20. Littell R.C., and Milliken G.A. SAS System for Mixed Models (2006), SAS Institute, Inc., Cary, NC
21. McCormack A.L., and Di Monte D.A. Effects of L-dopa and other amino acids against paraquat-induced nigrostriatal degeneration. J. Neurochem. 85 (2003) 82-86
22. McCormack A.L., Thiruchelvam M., Manning-Bog A.B., Thiffault C., Langston J.W., Cory-Slechta D.A., and Di Monte D.A. Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol. Dis. 10 2 (2002) 119-127
23. Nishi K., Kondo T., and Narabayashi H. Difference in recovery patterns of striatal dopamine content, tyrosine hydroxylase activity, and total bipterin content after 1-methyl-4-phenyl-1,2,3,6-tetrahyroperidine administration: a comparison of young and older mice. Brain Res. 489 1 (1989) 157-162
24. Prasad K., Winnik B., Thiruchelvam M.J., Buckley B., Mirochnitchenko O., and Richfield E.K. Prolonged toxicokinetics and toxicodynamics of paraquat in mouse brain. Environ. Health Perspect. 15 10 (2007) 1448-1453
25. Richardson J.R., Quan Y., Serer T.B., Greenamyre J.T., and Miller G.W. Paraquat neurotoxicity is distinct from that of MPTP and rotenone. Toxicol. Sci. 88 1 (2005) 193-201
26. Richardson J.R., Caudle W.M., Wang M., Dean E.D., Pennell K.D., and Miller G.W. Developmental exposure to the pesticide dieldrin alters the dopamine system and increases neurotoxicity in an animal model of Parkinson's disease. FASEB J. 20 (2006) 1695-1697
27. SAS Institute Inc. SAS/STAT® 9.1 User's Guide. Cary, NC.
28. Schmuck G., Rohrdanz E., Tran-Thi Q.H., Kahl R., and Schluter G. Oxidative stress in rat cortical neurons and astrocytes induced by paraquat in-vivo. Neurotoxicol. Res. 4 1 (2002) 1-13
29. Shimizu K., Ohtaki K., Matsubara K., Aoyama K., Vezono T., Saito O., Suno M., Ogawa K., and Hayase N. Carrier-mediated processes in blood-brain barrier penetration and neural uptake of paraquat. Brain Res. 906 1 (2001) 135-142
30. Simon J.R., Richter J.A., and Ghetti B. Age-dependent alterations in dopamine content, tyrosine hydroxylase activity, and dopamine uptake in the striatum of the Weaver mutant mouse. J. Neurochem. 62 2 (1994) 543-548
31. Smith L.L. Paraquat toxicity. Philos. Trans. R. Soc. London 311 (1985) 647-657
32. Smith P., and Heath D. Paraquat: Crit. Rev. Toxicol. 4 4 (1976) 411-445
33. Smith L.L., Rose M.S., and Wyatt I. The pathology and biochemistry of paraquat. CIBA Found. Symp. 65 (1978) 321-341
34. Thiruchelvam M., Brockel B.J., Richfield E.K., Baggs R.B., and Cory-Slechta D.A. Potential and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson's disease. Brain Res. 873 (2000) 225-234
35. Thiruchelvam M., Richfield E.K., Baggs R.B., Tank A.W., and Cory-Slechta D.A. The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease. J. Neurosci. 20 24 (2000) 9207-9214
36. 2. FEBS Lett. 128 2 (1981) 339-342
37. Wu X., Block M., Zhang W., Qin L., Wilson B., Zhang W., Veronesi B., and Hong J.S. The role of microglia in paraquat-induced dopaminergic neurotoxicity. Antioxid. Redox Signal. 7 (2005) 654-661
38. Yamada, Y., 2003. Paraquat (057): First Draft. 533-698. http://www.fao.org/ag/AGP/AGPP/Pesticid/JMPR/Download/2004_eva/paraquat.pdf.
39. Yang W., and Tiffany-Castiglioni E. The bipyridl herbicide paraquat produced oxidative stress-mediated toxicity in human neuroblastoma SH-SY5Y cells: relevance to the dopaminergic pathogenesis. J. Toxicol. Environ. Health 68 (2005) 1939-1961
40. Yang W., and Tiffany-Castiglioni E. The bipyridl herbicide paraquat induces proteasome dysfunction in human neuroblastoma SH-SY5Y cells. J. Toxicol. Environ. Health 70 (2007) 1849-1857